Sign inJoin waitlistJoin the waitlist

GP

Genovefa Papanicolaou

Clinical Director, Infectious Diseases · New York Presbyterian Hospital

Credentials: · · · ·

History

Infectious Diseases · New York Presbyterian Hospital
Present
Infectious Diseases · University of Washington School of Medicine
Present

Mount Sinai Hospital
1995–1996
Brown University School of Medicine
1994–1995
Infectious Disease
Corewell Health
1993–1994
Internal Medicine
Tufts University School of Medicine
1985–1988
National and Kapodistrian University of Athens School of Medicine
1981–1985

Research

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance…
Clinical Infectious Diseases · 2010 · 1,139 citations
Determinants of COVID-19 disease severity in patients with cancer
Nature Medicine · 2020 · 468 citations
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies
Review · Biology of Blood and Marrow Transplantation · 2003 · 335 citations

MP
Miguel-Angel Perales
46 papers
AJ
Ann Jakubowski
33 papers
SG
Sergio Giralt
29 papers
Susan Seo
26 papers
Roy Chemaly
25 papers
MK
Mini Kamboj
22 papers · 1 as a fellow
Yeon Lee
21 papers · 21 as a resident
Michael Boeckh
20 papers
SD
Sanjeet Dadwal
16 papers
Juliet Barker
15 papers
EP
Esperanza Papadopoulos
14 papers
KS
Kent Sepkowitz
14 papers

Grants

Site Specific Integration by Adeno Associated Virus
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $538.1K · Sloan-Kettering Inst Can Research
1999–2005

Clinical trials

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19
Principal investigator · Withdrawn · Phase 2
Memorial Sloan Kettering Cancer Center
2020
A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2019–2025
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
Principal investigator · Completed · Phase 4
Memorial Sloan Kettering Cancer Center
2010–2018
The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2003–2011